Rivaroxaban dosing in patients with atrial fibrillation: results from the RIVER registry – is dosing according to renal function appropriate?

Abstract Introduction Rivaroxaban is recommended as an option for anticoagulation in patients with nonvalvular atrial fibrillation (AF) with one or more risk factors for stroke. The approved/recommended rivaroxaban dose for stroke prevention in patients with atrial fibrillation (AF) is solely based...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European heart journal 2021-10, Vol.42 (Supplement_1)
Hauptverfasser:	Camm, A.J, Virdone, S, Fox, K.A.A, Pieper, K.S, Beyer-Westendorf, J, Le Heuzey, J.-Y, Haas, S, Kayani, G, Gersh, B.J, Turpie, A.G.G, Kakkar, A.K
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!